Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase

Background: Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myopericarditis (MP), in patients treated with immune checkpoint inhibitors (ICIs), is still conflicting. We explored this issue through a global real-world approach. Methods: We queried t...

Full description

Bibliographic Details
Main Authors: Milo Gatti, Emanuel Raschi, Ugo Moretti, Andrea Ardizzoni, Elisabetta Poluzzi, Igor Diemberger
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Vaccines
Subjects:
influenza vaccine
immune checkpoint inhibitors
myocarditis
pericarditis
pharmacovigilance
drug–vaccine interaction
Online Access:https://www.mdpi.com/2076-393X/9/1/19

Internet

https://www.mdpi.com/2076-393X/9/1/19

Similar Items